Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2788

Sort by

Sort Order Select

Journal Articles

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Pengpeng Xu, YUE ZHU, Zi-Yang Shi, Li Wang, Shu Cheng, Ying Qian, Yan Zhao, Yang He, Hongmei Yi, Binshen Ouyang, Xu-Feng Jiang, Biao Li, Qi Song, Rong-Ji Mu, Weili Zhao

Blood blood.2025028649.

https://doi.org/10.1182/blood.2025028649

Published: 2025

Includes: Supplemental data

Journal Articles

Epigenetic changes by EZH2 inhibition increase translocations in B cells with high AID activity or DNA repair deficiency

Jianli Tao, Luca Alessandri, Alessandro Gasparetto, Lijuan Zhao, Xuefei Zhang, Frederick W Alt, Roberto Chiarle

Blood blood.2024026131.

https://doi.org/10.1182/blood.2024026131

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

Colleen Annesley, Kristy Seidel, Qian Wu, Corinne Summers, Alan S. Wayne, Michael A. Pulsipher, Anurag K. Agrawal, Chris T. Brown, Stephanie Mgebroff, Catherine Lindgren, Stephanie Rawlings-Rhea, Wenjun Huang, Ashley L. Wilson, Michael C. Jensen, Julie R. Park, Rebecca A. Gardner

Blood (2025) 146 (7): 789–801.

https://doi.org/10.1182/blood.2025028359

Published: 2025

Includes: Supplemental data

Journal Articles

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Blood (2025) 146 (7): 834–846.

https://doi.org/10.1182/blood.2025028833

Published: 2025

Includes: Supplemental data

Journal Articles

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia

Anna Saorin, Anna Dehler, Bartimée Galvan, Fabio Steffen, Marine Ray, Dong Lu, Xin Yu, James Kim, Aneta Drakul, Samanta Kisele, Jin Wang, Jean-Pierre Bourquin, Beat C. Bornhauser

Blood (2025) 146 (7): 861–873.

https://doi.org/10.1182/blood.2025028938

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

Blood (2025) 146 (7): 819–833.

https://doi.org/10.1182/blood.2024025536

Published: 2025

Includes: Supplemental data

Journal Articles

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Blood (2025) 146 (7): 847–860.

https://doi.org/10.1182/blood.2025028746

Published: 2025

Includes: Supplemental data

Journal Articles

Hitting the therapeutic bull’s-eye with targeted therapy for patients with chronic lymphocytic leukemia

William G. Wierda, Barbara Eichhorst, Michael Hallek

Blood (2025) 146 (7): 779–788.

https://doi.org/10.1182/blood.2025028570

Published: 2025

Journal Articles

Eliminating the need for sequential confirmation of response in multiple myeloma

Blood (2025) 146 (7): 802–805.

https://doi.org/10.1182/blood.2024027949

Published: 2025

Includes: Supplemental data

Journal Articles

Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma

Lianqun Qiu, Beenu Thakral

Blood (2025) 146 (7): 897.

https://doi.org/10.1182/blood.2025029859

Published: 2025

Journal Articles

Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?

Carla Casulo, Laurie H. Sehn

Blood blood.2024026018.

https://doi.org/10.1182/blood.2024026018

Published: 2025

Journal Articles

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL

Blood blood.2025029785.

https://doi.org/10.1182/blood.2025029785

Published: 2025

Includes: Supplemental data

Journal Articles

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

Smith Giri, Binod Dhakal, Natalie S. Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai R. Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano Costa

Blood (2025) 146 (6): 707–716.

https://doi.org/10.1182/blood.2024027674

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission

Ibrahim Aldoss, Mary C. Clark, Stephen J. Forman

Blood (2025) 146 (6): 667–678.

https://doi.org/10.1182/blood.2024027267

Published: 2025

Journal Articles

Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results

Blood (2025) 146 (6): 679–692.

https://doi.org/10.1182/blood.2024027620

Published: 2025

Includes: Supplemental data

Journal Articles

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes

Blood (2025) 146 (5): 571–584.

https://doi.org/10.1182/blood.2024026236

Published: 2025

Includes: Supplemental data

Journal Articles

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

Blood (2025) 146 (5): 585–589.

https://doi.org/10.1182/blood.2024027175

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Blood (2025) 146 (5): 535–545.

https://doi.org/10.1182/blood.2024027681

Published: 2025

Includes: Supplemental data

Journal Articles

Immunoglobulin-containing vacuoles in CLL

Adnan Qamar, Chen Zhao

Blood (2025) 146 (5): 647.

https://doi.org/10.1182/blood.2025028670

Published: 2025

Journal Articles

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection

Blood blood.2024026805.

https://doi.org/10.1182/blood.2024026805

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Epigenetic changes by EZH2 inhibition increase translocations in B cells with high AID activity or DNA repair deficiency

Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Hitting the therapeutic bull’s-eye with targeted therapy for patients with chronic lymphocytic leukemia

Eliminating the need for sequential confirmation of response in multiple myeloma

Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma

Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission

Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Immunoglobulin-containing vacuoles in CLL

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only